vs
FORWARD AIR CORP（FWRD）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是FORWARD AIR CORP的1.2倍（$772.1M vs $631.2M），Revvity净利率更高（12.7% vs -4.5%，领先17.2%），Revvity同比增速更快（5.9% vs -0.3%），过去两年Revvity的营收复合增速更高（9.0% vs 7.9%）
Forward Air Corp是北美领先的轻资产物流运输服务商，核心业务包括加急零担货运、最后一公里配送、多式联运、仓储及供应链解决方案，服务覆盖美加墨地区，主要服务电商、零售、制造、汽车等行业。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FWRD vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.2倍
$631.2M
营收增速更快
RVTY
高出6.1%
-0.3%
净利率更高
RVTY
高出17.2%
-4.5%
两年增速更快
RVTY
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $631.2M | $772.1M |
| 净利润 | $-28.3M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | -0.5% | 14.5% |
| 净利率 | -4.5% | 12.7% |
| 营收同比 | -0.3% | 5.9% |
| 净利润同比 | 22.2% | 3.9% |
| 每股收益（稀释后） | $-0.90 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FWRDRVTY
| Q4 25 | $631.2M | $772.1M | ||
| Q3 25 | $631.8M | $698.9M | ||
| Q2 25 | $618.8M | $720.3M | ||
| Q1 25 | $613.3M | $664.8M | ||
| Q4 24 | $632.8M | $729.4M | ||
| Q3 24 | $655.9M | $684.0M | ||
| Q2 24 | $643.7M | $691.7M | ||
| Q1 24 | $541.8M | $649.9M |
净利润FWRDRVTY
| Q4 25 | $-28.3M | $98.4M | ||
| Q3 25 | $-16.3M | $46.7M | ||
| Q2 25 | $-12.6M | $53.9M | ||
| Q1 25 | $-50.6M | $42.2M | ||
| Q4 24 | $-36.4M | $94.6M | ||
| Q3 24 | $-73.4M | $94.4M | ||
| Q2 24 | $-645.4M | $55.4M | ||
| Q1 24 | $-61.7M | $26.0M |
毛利率FWRDRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率FWRDRVTY
| Q4 25 | -0.5% | 14.5% | ||
| Q3 25 | 2.4% | 11.7% | ||
| Q2 25 | 3.2% | 12.6% | ||
| Q1 25 | 0.8% | 10.9% | ||
| Q4 24 | 12.0% | 16.3% | ||
| Q3 24 | 3.5% | 14.3% | ||
| Q2 24 | -170.2% | 12.4% | ||
| Q1 24 | -12.1% | 6.8% |
净利率FWRDRVTY
| Q4 25 | -4.5% | 12.7% | ||
| Q3 25 | -2.6% | 6.7% | ||
| Q2 25 | -2.0% | 7.5% | ||
| Q1 25 | -8.3% | 6.4% | ||
| Q4 24 | -5.8% | 13.0% | ||
| Q3 24 | -11.2% | 13.8% | ||
| Q2 24 | -100.3% | 8.0% | ||
| Q1 24 | -11.4% | 4.0% |
每股收益（稀释后）FWRDRVTY
| Q4 25 | $-0.90 | $0.86 | ||
| Q3 25 | $-0.52 | $0.40 | ||
| Q2 25 | $-0.41 | $0.46 | ||
| Q1 25 | $-1.68 | $0.35 | ||
| Q4 24 | $-1.69 | $0.77 | ||
| Q3 24 | $-2.66 | $0.77 | ||
| Q2 24 | $-23.47 | $0.45 | ||
| Q1 24 | $-2.81 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $106.0M | $919.9M |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $113.3M | $7.3B |
| 总资产 | $2.7B | $12.2B |
| 负债/权益比越低杠杆越低 | 14.89× | — |
8季度趋势，按日历期对齐
现金及短期投资FWRDRVTY
| Q4 25 | $106.0M | $919.9M | ||
| Q3 25 | $140.4M | $931.4M | ||
| Q2 25 | $95.1M | $991.8M | ||
| Q1 25 | $116.3M | $1.1B | ||
| Q4 24 | $104.9M | $1.2B | ||
| Q3 24 | $136.6M | $1.2B | ||
| Q2 24 | $84.9M | $2.0B | ||
| Q1 24 | $152.0M | $1.7B |
总债务FWRDRVTY
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $1.7B | — |
股东权益FWRDRVTY
| Q4 25 | $113.3M | $7.3B | ||
| Q3 25 | $139.8M | $7.4B | ||
| Q2 25 | $151.8M | $7.6B | ||
| Q1 25 | $154.6M | $7.6B | ||
| Q4 24 | $201.7M | $7.7B | ||
| Q3 24 | $226.1M | $7.9B | ||
| Q2 24 | $283.8M | $7.9B | ||
| Q1 24 | $926.1M | $7.8B |
总资产FWRDRVTY
| Q4 25 | $2.7B | $12.2B | ||
| Q3 25 | $2.8B | $12.1B | ||
| Q2 25 | $2.8B | $12.4B | ||
| Q1 25 | $2.8B | $12.4B | ||
| Q4 24 | $2.8B | $12.4B | ||
| Q3 24 | $3.1B | $12.8B | ||
| Q2 24 | $3.1B | $13.4B | ||
| Q1 24 | $4.0B | $13.4B |
负债/权益比FWRDRVTY
| Q4 25 | 14.89× | — | ||
| Q3 25 | 12.05× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.81× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | 1.3% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流FWRDRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $52.7M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | $27.6M | $128.2M | ||
| Q4 24 | $-23.2M | $174.2M | ||
| Q3 24 | $51.2M | $147.9M | ||
| Q2 24 | $-45.2M | $158.6M | ||
| Q1 24 | $-51.7M | $147.6M |
自由现金流FWRDRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $48.6M | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | $15.7M | $112.2M | ||
| Q4 24 | $-30.5M | $149.8M | ||
| Q3 24 | $40.7M | $125.6M | ||
| Q2 24 | $-59.6M | $136.6M | ||
| Q1 24 | $-56.7M | $129.7M |
自由现金流率FWRDRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 7.7% | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | 2.6% | 16.9% | ||
| Q4 24 | -4.8% | 20.5% | ||
| Q3 24 | 6.2% | 18.4% | ||
| Q2 24 | -9.3% | 19.7% | ||
| Q1 24 | -10.5% | 20.0% |
资本支出强度FWRDRVTY
| Q4 25 | 1.3% | 2.6% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 0.8% | 2.6% | ||
| Q1 25 | 1.9% | 2.4% | ||
| Q4 24 | 1.1% | 3.4% | ||
| Q3 24 | 1.6% | 3.3% | ||
| Q2 24 | 2.2% | 3.2% | ||
| Q1 24 | 0.9% | 2.7% |
现金转化率FWRDRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FWRD
| Omni Logistics Segment | $359.8M | 57% |
| Network | $183.9M | 29% |
| Intermodal Segment | $50.2M | 8% |
| Truckload | $41.6M | 7% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
